|3 Months Ended|
Mar. 31, 2021
Note 8. Stockholders’ Equity
The 2015 Omnibus Incentive Plan provides for the issuance of stock options, stock appreciation rights, performance shares,
performance units, restricted stock, restricted stock units, shares of our common stock, dividend equivalent units, incentive cash
awards or other awards based on our common stock. Awards may be granted alone or in addition to, in tandem with, or (subject to the
2015 Omnibus Incentive Plan’s prohibitions on repricing) in substitution for any other award (or any other award granted under
another plan of ours or of any of our affiliates).
The following is a summary of the stock option plan activity during the Three Months ended March 31, 2021 and 2020:
Compensation expense recognized from the vesting of stock options was approximately $nil and $3,400 for the Three Months ended March 31, 2021 and 2020. There was no unrecognized compensation cost associated with unvested stock options as of March 31, 2021.
The aggregate intrinsic value of the outstanding common stock options as of March 31, 2021 and December 31, 2020 was approximately $0 and $0 respectively.
The following is a summary of the warrant activity during the Three Months ended March 31, 2021 and 2020:
During the three months ended March 31, 2021, the Company received approximately $9.5 million upon the exercise by warrant holders of warrants for approximately 2.3 million shares. The aggregate intrinsic value of the outstanding common stock warrants as of March 31, 2021 and December 31, 2020 was approximately $797,000 and $256,400 respectively.
No definition available.
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
Reference 1: http://www.xbrl.org/2003/role/disclosureRef